Treatment of Hypertension With Adalat® in Combination With Other Drugs

Bayer

Status: Completed

Conditions: Hypertension

Treatments: Drug: Nifedipine (Adalat, BAYA1040)

Study type: Observational

Funder types: Industry

Identifiers

NCT01118286

AdADOSE (Other Identifier)

14296

AL0701 (Other Identifier)

Details and patient eligibility

About

To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.

Enrollment: 4,497 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Previously untreated hypertensive patients starting with combination therapy containing nifedipine or
• Insufficiently controlled hypertensive pts. receiving nifedipine as an add-on to existing non-CCB (calcium-channel-blocker) containing antihypertensive therapy

Exclusion criteria

• None. Exclusion criteria are defined by contraindications and precautions as stated in the local product information.

Trial design

4,497 participants in 1 patient group

Group 1

Treatment:

Drug: Nifedipine (Adalat, BAYA1040)